Home » Trends in Immunotherapy

Immunological and Clinical Implications of Surgical Techniques in Primary Inguinal Hernia Repair: Autoplasty and Alloplasty Compared

Kanat Mamakeev
Department of Scientific, National Surgical Center Named after M.M. Mamakeev, Ministry of Health of the Kyrgyz Republic, Bishkek 720000, Kyrgyzstan
Zhanybek Ashimov
Department of Scientific, National Surgical Center Named after M.M. Mamakeev, Ministry of Health of the Kyrgyz Republic, Bishkek 720000, Kyrgyzstan
Urmat Aitiev
Department of General Surgery, Kyrgyz State Medical Institute, Retraining/Advanced Training Named after S.B. Daniyarov, Bishkek 720017, Kyrgyzstan
Batyrkhan Niyazov
Department of General Surgery, Kyrgyz State Medical Institute, Retraining/Advanced Training Named after S.B. Daniyarov, Bishkek 720017, Kyrgyzstan
Omar Dinlossan
Department of Scientific, National Surgical Center Named after M.M. Mamakeev, Ministry of Health of the Kyrgyz Republic, Bishkek 720000, Kyrgyzstan
Sardar Kayumov
Department of Scientific, National Surgical Center Named after M.M. Mamakeev, Ministry of Health of the Kyrgyz Republic, Bishkek 720000, Kyrgyzstan
Tugolbai Tagaev ORCID
Department of Hospital Internal Medicine, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek 720020, Kyrgyzstan

Received: 31 March 2026; Revised: 23 April 2026; Accepted: 29 May 2026; Published: 11 June 2026

Abstract

Inguinal hernia repair is performed over 20 million times annually, with outcomes reflecting mechanical reconstruction and immune activation. This study compared autoplasty and tension-free alloplasty for primary inguinal hernias, focusing on clinical outcomes and inflammatory responses. This prospective single-center study compared tissue-based autoplasty (Shouldice/Spasokukotsky) with tension-free mesh alloplasty (Lichtenstein) in 118 adults (mean age 46 ± 12.1 years; 93% male; autoplasty, n = 50; alloplasty, n = 68). Pain (verbal descriptor scale), complications, hospital stay, and systemic markers (C-reactive protein, neutrophil-to-lymphocyte ratio, interleukin-6, tumor necrosis factor-alpha, lymphocyte count) were assessed (p < 0.05). Alloplasty showed faster operation (48.4 ± 1.5 vs. 59.6 ± 2.6 min), less pain (day 1: 4.5 ± 0.5 vs. 5.7 ± 0.6; day 2: 1.1 ± 0.2 vs. 2.4 ± 0.3; day 5: 0.5 ± 0.1 vs. 1.2 ± 0.2), earlier walking (7.2 ± 2.1 vs. 21.4 ± 3.6 h), fewer complications (8.4% vs. 28.8%), and reduced hospitalization (3.6 ± 0.9 vs. 5.1 ± 1.2 days; all p < 0.05). Autoplasty showed higher inflammatory markers (C-reactive protein 32.5 ± 6.8 vs. 21.3 ± 5.4 mg/L; neutrophil-to-lymphocyte ratio 5.8 ± 1.2 vs. 3.9 ± 0.9; interleukin-6 48.7 ± 10.2 vs. 29.4 ± 8.6 pg/mL; tumor necrosis factor-alpha 26.5 ± 7.3 vs. 17.2 ± 5.8 pg/mL; all significant). Operative time was correlated with pain (r = 0.64; p < 0.01) and complications (r = 0.48; p < 0.05). Tension-free alloplasty improved recovery and reduced immune activation; however, non-randomization, single-center design, and limited follow-up constrain long-term inferences of the study.

Keywords

References

×